Control of Risk Factors for Cardiovascular Disease among Multinational Patient Population in the Arabian Gulf.
We evaluated the control of cardiovascular disease (CVD) risk factors among patients with atherosclerotic cardiovascular disease (ASCVD) in the Centralized Pan-Middle East Survey on the undertreatment of hypercholesterolaemia (CEPHEUS) in the Arabian Gulf. Of the 4398 enrolled patients, overall mean age was 57 ± 11 years, 60% were males, 13% were smokers, 76% had diabetes, 71% had metabolic syndrome and 78% had very high ASCVD risk status. The proportion of subjects with body mass index <25 kgm2, HbA1c <7% (in diabetics), low-density lipoprotein cholesterol (LDL-C) <2.6 mmol/L (100 mg/dL) and <1.8 mmol/L (70 mg/dL) for high and very high ASCVD risk cohorts, respectively and controlled blood pressure (<140/90 mmHg) was 14, 26, 31% and 60%, respectively. Only 1.4% of the participants had all of their CVD risk factors controlled with significant differences among the countries (P < .001). CVD risk goal attainment rates were significantly lower in those with very high ASCVD risk compared with those with high ASCVD risk status (P < .001). Females were also, generally, less likely to attain goals when compared with males (P < .001).
Ibrahim
I
Al-Zakwani
Wael
W
Al-Mahmeed
Mohamed
M
Arafah
Ali T
AT
Al-Hinai
Abdullah
A
Shehab
Omer
O
Al-Tamimi
Mahmoud
M
Al-Awadhi
Shorook
S
Al-Herz
Faisal
F
Al-Anazi
Khalid
K
Al-Nemer
Othman
O
Metwally
Akram
A
Al-Khadra
Mohammed
M
Fakhry
Hossam
H
Elghetany
Abdel R
AR
Medani
Afzal H
AH
Yusufali
Obaid
O
Al-Jassim
Omar
O
Al-Hallaq
Fahad O A S
FO
Baslaib
Haitham
H
Amin
Raul D
RD
Santos
Khalid
K
Al-Waili
Khamis
K
Al-Hashmi
Department of Biochemistry, Sultan Qaboos University Hospital, P.O. Box 38, Al-Khod, Muscat 123, Oman. k.alrasadi@gmail.com.
Khalid
K
Al-Rasadi
D000328:Adult; D000368:Aged; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D003430:Cross-Sectional Studies; D003920:Diabetes Mellitus / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D006973:Hypertension / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D024821:Metabolic Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D008875:Middle Aged; D008877:Middle East / Q000453:epidemiology; D009765:Obesity / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D015995:Prevalence; D018570:Risk Assessment; D012307:Risk Factors; D012737:Sex Factors; D012907:Smoking / Q000009:adverse effects / Q000453:epidemiology
D000960:Hypolipidemic Agents